Phase 1/2a DTA-H19 in Patients With Unresectable Pancreatic Cancer
Clinical trial NCT00711997 · COMPLETED
Trial details
- NCT number
- NCT00711997
- Sponsor
- Anchiano Therapeutics Israel Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2010-10-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.